Ask the Expert: My Melanoma Therapy Stopped Working, What's Next?


Michael A. Postow, MD

Chief, Melanoma Service, Associate Attending Physician

Memorial Sloan Kettering Cancer Center

Michael Postow is a medical oncologist and the Chief of the Melanoma Service at Memorial Sloan Kettering Cancer Center. He led the first randomized trial of combination immune checkpoint inhibition (nivolumab + ipilimumab), resulting in its FDA approval. He has also written and presented on topics related to immunotherapy outcomes and side effects and studied new ways to combine immunotherapy with local treatments (i.e. radiation).  His completed and ongoing work continue to impact cancer patients and advance immunotherapy for melanoma and other diseases. He enjoys skiing, outdoor activities, and trying to keep up with his two toddlers and triathlete wife.

Bennie Lunsford

Bennie Lunsford has had stage 4 cancer since 2013 and was stage 2 in 2005. He has pretty much done almost all the treatments you can think of. He has a wife, Janet, that he owes his reason for still being here. She was the one that was instrumental in finding the trial and treatments that allow him to be here today. Bennie has two children, Colby who is 13 and Emmi who is 16. He lives in Houston, Texas and is the IT Director for an engineering firm.  


Post-webinar evaluation
4 Questions
Ask the Expert: My Melanoma Therapy Stopped Working, What's Next?
Recorded 07/24/2023  |  60 minutes
Recorded 07/24/2023  |  60 minutes On July 24, the MRF held an informative discussion featuring Dr. Michael A. Postow, Chief, Melanoma Service, Co-Director, Melanoma Disease Management Team and Associate Attending Physician from Memorial Sloan Kettering Cancer Center and patient advocate and panelist Bennie Lunsford. Special thanks #Replimune for sponsoring this important educational opportunity.